Zim Laboratories Profit & Loss Annual

BSE: 541400 | NSE: ZIMLAB | ISIN: INE518E01015 | Sector: Biotechnology & Drugs

107.00 +2.85 (2.74%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	367.42	398.53	333.43	307.26
Total Revenue	367.42	398.53	333.43	307.26
Costof Revenue Total	171.44	210.90	170.26	166.16
Gross Profit	195.98	187.63	163.17	141.10
Selling/ General/ Admin Expenses Total	53.34	130.64	117.10	98.29
Depreciation/ Amortization	15.95	17.47	16.03	15.79
Other Operating Expenses Total	101.31	4.35	5.08	3.05
Total Operating Expense	342.04	363.35	308.48	288.47
Operating Income	25.38	35.18	24.95	18.79
Interest Inc( Exp) Net- Non- Op Total	-69.24	11.21	-29.05	-74.03
Other Net	5.18	-0.28	-1.00	-1.16
Net Income Before Taxes	23.64	35.36	21.04	10.23
Provisionfor Income Taxes	6.40	10.92	6.49	2.91
Net Income After Taxes	17.25	24.43	14.55	7.32
Net Income Before Extra Items	17.25	24.43	14.55	7.32
Net Income	17.25	24.43	14.55	7.32
Income Availableto Com Excl Extra Ord	17.25	24.43	14.55	7.32
Income Availableto Com Incl Extra Ord	17.25	24.43	14.55	7.32
Diluted Net Income	17.25	24.43	14.55	7.32
Diluted Weighted Average Shares	4.87	4.87	1.62	1.62
Diluted EPS Excluding Extra Ord Items	3.54	5.01	8.96	4.51
Diluted Normalized EPS	3.54	5.11	8.96	6.79
Gain( Loss)on Saleof Assets	-	-6.60	-0.03	0.00
Unusual Expense( Income)	-	-	0.00	5.18